Newron Pharmaceuticals Spa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Newron Pharmaceuticals Spa with three other
miscellaneous service companies in Europe:
Sprint Bioscience AB
sales of 34.99 million Swedish Kronor [US$3.98 million]
of the United Kingdom
(£5.06 million [US$6.32 million]
of which 40%
was Preclinical Research services), and
based in the United Kingdom
(£3.11 million [US$3.88 million]
of which 100%
During the year ended December of 2016, sales at
Newron Pharmaceuticals Spa were 4.74 million Euro (US$5.12 million).
increase of 108.2%
versus 2015, when the company's sales were 2.28 million Euro.